BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36442137)

  • 1. Increase of atypical fibroxanthoma and pleomorphic dermal sarcoma: a retrospective analysis of four German skin cancer centers.
    Kuntz T; Siebdrath J; Hofmann SC; Baltaci M; Schaller J; Hellmich M; von Goltzheim LS; Assaf C; Oellig F; Michalowitz AL; Helbig D; Kreuter A
    J Dtsch Dermatol Ges; 2022 Dec; 20(12):1581-1588. PubMed ID: 36442137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma.
    Soleymani T; Tyler Hollmig S
    Curr Treat Options Oncol; 2017 Aug; 18(8):50. PubMed ID: 28762020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrochlorothiazide and increased risk of atypical fibroxanthoma and pleomorphic dermal sarcoma.
    Kuntz T; Grimm A; Hofmann SC; Michalowitz AL; Schaller J; Hellmich M; Assaf C; Oellig F; Kreuter A
    J Dtsch Dermatol Ges; 2024 Apr; 22(4):513-519. PubMed ID: 38483049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical Characteristics of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: A Systematic Review and Meta-Analysis.
    Ørholt M; Abebe K; Aaberg F; Rasmussen LE; Daugaard S; Loya AC; Herly M; Vester-Glowinski PV
    Am J Dermatopathol; 2022 Dec; 44(12):913-920. PubMed ID: 36395448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS).
    Helbig D; Ziemer M; Dippel E; Erdmann M; Hillen U; Leiter U; Mentzel T; Osterhoff G; Ugurel S; Utikal J; von Bubnoff D; Weishaupt C; Grabbe S
    J Dtsch Dermatol Ges; 2022 Feb; 20(2):235-243. PubMed ID: 35099104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The many faces of Atypical fibroxanthoma.
    Agaimy A
    Semin Diagn Pathol; 2023 Jul; 40(4):306-312. PubMed ID: 37438163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical fibroxanthoma and pleomorphic dermal sarcoma - gene expression analysis compared with undifferentiated cutaneous squamous cell carcinoma.
    Anders IM; Schimmelpfennig C; Wiedemann K; Löffler D; Kämpf C; Blumert C; Reiche K; Kunz M; Anderegg U; Simon JC; Ziemer M
    J Dtsch Dermatol Ges; 2023 May; 21(5):482-491. PubMed ID: 37035902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical fibroxanthoma and pleomorphic dermal sarcoma: Is superficial infiltration in subcutaneous tissue acceptable in AFX?
    van Midden D; Flucke UE; Amir AL; Bonenkamp JJ; Lubeek SFK; Blokx WAM
    Ann Diagn Pathol; 2022 Jun; 58():151915. PubMed ID: 35276548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
    Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
    Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleomorphic Dermal Sarcoma.
    Saleh JS; Whittington CP; Bresler SC; Patel RM
    Surg Pathol Clin; 2024 Mar; 17(1):153-158. PubMed ID: 38278604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleomorphic dermal sarcoma in a man with HIV: report with next-generation sequencing analysis and review of the atypical fibroxanthoma/pleomorphic dermal sarcoma spectrum.
    Chen SX; Eichenfield DZ; Orme C; Hinds B
    Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.
    Miller TI; Zoumberos NA; Johnson B; Rhodes DR; Tomlins SA; Chan MP; Andea AA; Lucas DR; McHugh JB; Smith N; Harms KL; Brewer C; Saleh J; Patel RM; Harms PW
    Hum Pathol; 2020 Aug; 102():60-69. PubMed ID: 32540221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical fibroxanthoma/pleomorphic dermal sarcoma of the scalp with aberrant expression of HMB-45: a pitfall in dermatopathology.
    Piras V; Ferreli C; Atzori L; Pinna G; Pilloni L
    Pathologica; 2020 Jun; 112(2):105-109. PubMed ID: 32760054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleomorphic Dermal Sarcoma: A Clinical and Histopathologic Emulator of Atypical Fibroxanthoma, but Different Biologic Behavior.
    Carletti M; Nguyen DA; Malouf P; Ingersoll Z; Hosler GA; Weis SE
    HCA Healthc J Med; 2022; 3(5):299-304. PubMed ID: 37425251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical fibroxanthoma with pseudoangiomatous features: a histological and immunohistochemical mimic of cutaneous angiosarcoma.
    Thum C; Husain EA; Mulholland K; Hornick JL; Brenn T
    Ann Diagn Pathol; 2013 Dec; 17(6):502-7. PubMed ID: 24080496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomas.
    Helbig D; Ihle MA; Pütz K; Tantcheva-Poor I; Mauch C; Büttner R; Quaas A
    Oncotarget; 2016 Apr; 7(16):21763-74. PubMed ID: 26943575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide methylation profiling and copy number analysis in atypical fibroxanthomas and pleomorphic dermal sarcomas indicate a similar molecular phenotype.
    Koelsche C; Stichel D; Griewank KG; Schrimpf D; Reuss DE; Bewerunge-Hudler M; Vokuhl C; Dinjens WNM; Petersen I; Mittelbronn M; Cuevas-Bourdier A; Buslei R; Pfister SM; Flucke U; Mechtersheimer G; Mentzel T; von Deimling A
    Clin Sarcoma Res; 2019; 9():2. PubMed ID: 30809375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical fibroxanthoma and pleomorphic dermal sarcoma: Local recurrence and metastasis in a nationwide population-based cohort of 1118 patients.
    Ørholt M; Abebe K; Rasmussen LE; Aaberg FL; Lindskov LJ; Schmidt G; Wagenblast AL; Petersen MM; Loya AC; Daugaard S; Herly M; Jensen DH; Vester-Glowinski P
    J Am Acad Dermatol; 2023 Dec; 89(6):1177-1184. PubMed ID: 37634740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical fibroxanthoma-a diagnosis of exclusion!
    Tchernev G; Tronnier M; Ananiev J; Taneva T; Patterson JW; Gulubova M; Trafeli JP; Gegova A; Harrell M; Guarneri C; Wollina U; Cardoso JC; Kanazawa N; Zisova L; Forsea AM; Zouboulis CC
    Wien Med Wochenschr; 2013 Aug; 163(15-16):380-6. PubMed ID: 23319144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clear cell variant of atypical fibroxanthoma and pleomorphic dermal sarcoma: Molecular characterization and review of the literature.
    Coelho-Lima J; Bruty J; Watkins J; Liu H; Price R; Stefanos N
    J Cutan Pathol; 2022 Dec; 49(12):1031-1034. PubMed ID: 35922373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.